Independent. Trusted. Proven.
Investment analysis, share recommendations, and market insights.
Anecdotal evidence from many tourism operators points to Aussie travellers rethinking travel plans to travel at home – where the Australian dollar will always be an Australian dollar. Here are two potential exposures that analysts think represent good value.
While this precious metal rally may have further to run, some profit-taking is prudent, but hear me out why I say this.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, explains why he expects Pinnacle Investment (PNI) to rally higher from here.
There are pockets of value still to be mined in the sector. Here are two mid-tier gold producers that fit the bill very nicely.
Here’s an undervalued Listed Investment Company (LIC) to consider, and another idea for the watchlist.
In our “HOT” stock article today, Michael Gable, MD of Fairmont Equities, says that with China banning the exports of rare earths to the US, Lynas Rare Earths (LYC) is a buy again.
You never want a serious crisis to go to waste so let me tell you the six quality stocks I’ll be buying as soon as I think ‘normalcy’ is back.
Let’s check out Spark New Zealand (SPK) and APA Group to determine if these two stocks are in the buy zone or should be dropped.
In our “HOT STOCK” column today, Raymond Chan, Head of Asian Desk, gives us a rundown on what tariffs apply to various pharma stocks and which pharma he sees as an ADD to an investor’s portfolio.
The outlook for CSL (one of the few true global leaders on the ASX) from the analysts (who aren’t always right) is that the recent price decline gives investors an improved access point to a high-quality global healthcare exposure. Let’s put CSL under the microscope.
You don't have credit card details available. You will be redirected to update payment method page. Click OK to continue.